drugset / Trial / NCT07848334
First-in-Human Safety and Tolerability Study of OPF-110 in Healthy Adults
RandomizedParallel-groupSingle-blindTreatment
Summary
This study will evaluate the safety and tolerability of OPF-110 in healthy adult participants.
Timeline
- Start
- 2026-08-12
- Primary completion
- 2026-10
- Completion
- 2026-10
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | OPF-110 | Other / unclassified | — | Intravenous |
| Comparator | SMOFlipid | Other / unclassified | — | Intravenous |
Indications
No indication recorded.